Arabic Arabic English English French French German German
dark

Myeloid Therapeutics Appoints Leading Immunologist, Cell and Gene Therapy Expert Bruce McCreedy, Ph.D., as Chief Scientific Officer

Dr. McCreedy brings decades of executive-level biopharmaceutical experience to advance research and development of novel myeloid-targeting therapies. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Expansions and Hirings Spark Surge of Growth in BioCapital Region

Next Post

Sherlock Biosciences’ CRISPR SARS-CoV-2 Test Selected as Finalist in “On the Rise” and Honorable Mention in “Health and Pandemic Response” Categories of Fast Company’s 2021 World Changing Ideas Awards

Related Posts
Total
0
Share